Altermune Technologies karymullis.com


Public lists: Pharma Startups (4732)

Altermune Technologies develops therapeutics to combat drug-resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza.

Altermune Technologies develops therapeutics to combat drug-resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza.

Company (Alive / Active)

Phone:

Fax:

2875 Michelle Drive
Suite 300
Irvine, 92606
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Altermune Technologies $7M Sep 22, 2011

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Altermune Technologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Chemically programmable immunity Jul 06, 2012 Nov 26, 2013 Patent
Chemically programmable immunity Jan 11, 2010 Sep 11, 2012 Patent
Chemically programmable immunity Dec 17, 2008 Aug 07, 2012 Patent
Chemically programmable immunity Nov 30, 2006 Dec 14, 2010 Patent
Chemically programmable immunity Jan 09, 2004 Jan 12, 2010 Patent
See all 6 patents